Male Osteoporosis - 07/08/12
Doi : 10.1016/j.ecl.2012.05.001
Matthew T. Drake, MD, PhD ⁎ 
, Sundeep Khosla, MD
, Sundeep Khosla, MD Department of Medicine, Division of Endocrinology, College of Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
Corresponding author. Endocrine Research Unit, Guggenheim 7-11, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905.Résumé |
Osteoporosis is now recognized as a major threat to health in aging men. Morbidity and mortality, particularly following hip fracture, are substantial. Although trabecular bone loss starts in early adulthood, loss of cortical bone only seems to occur from midlife onwards. Declining bioavailable estradiol levels plays an integral role in male age-associated bone loss. Both pharmacologic and supportive care interventions are important for optimal care in men at an increased fracture risk.
Le texte complet de cet article est disponible en PDF.Keywords : Osteoporosis, Men, Fracture, Epidemiology, DXA, QCT, Sex steroids
Plan
© 2012
Elsevier Inc. Tous droits réservés.
Vol 41 - N° 3
P. 629-641 - septembre 2012 Retour au numéro
Article précédent
- Unrecognized and Unappreciated Secondary Causes of Osteoporosis
- Paul D. Miller
- Combination Anabolic and Antiresorptive Therapy for Osteoporosis
- Natalie E. Cusano, John P. Bilezikian
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?